| 000 | 01611 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517143555.0 | ||
| 264 | 0 | _c20181211 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/srep44700 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLohberger, Birgit | |
| 245 | 0 | 0 |
_aEstablishment of a novel cellular model for myxofibrosarcoma heterogeneity. _h[electronic resource] |
| 260 |
_bScientific reports _c03 2017 |
||
| 300 |
_a44700 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCarcinogenesis _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xgenetics |
| 650 | 0 | 4 |
_aCell Proliferation _xgenetics |
| 650 | 0 | 4 |
_aChromosomes, Human _xgenetics |
| 650 | 0 | 4 | _aClone Cells |
| 650 | 0 | 4 |
_aDNA Copy Number Variations _xgenetics |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrosarcoma _xdrug therapy |
| 650 | 0 | 4 | _aGenetic Heterogeneity |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHigh-Throughput Nucleotide Sequencing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aModels, Biological |
| 700 | 1 | _aStuendl, Nicole | |
| 700 | 1 | _aLeithner, Andreas | |
| 700 | 1 | _aRinner, Beate | |
| 700 | 1 | _aSauer, Stefan | |
| 700 | 1 | _aKashofer, Karl | |
| 700 | 1 | _aLiegl-Atzwanger, Bernadette | |
| 773 | 0 |
_tScientific reports _gvol. 7 _gp. 44700 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep44700 _zAvailable from publisher's website |
| 999 |
_c26978627 _d26978627 |
||